Next report date
Report period
Q1 2024
EPS estimate
−0.21USD
Revenue estimate
—
−2.51USD
−89.54 MUSD
41.44 M
About Structure Therapeutics Inc.
Sector
CEO
Raymond C. Stevens
Website
Headquarters
South San Francisco
Employees (FY)
93
Founded
2019
FIGI
BBG01CBVHLW1
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
